FDA-approved epilepsy drug may help reverse osteoarthritis damage - ScienceDaily
SciencedailyOctober 8, 2026
Researchers at Yale have identified a promising new approach to osteoarthritis that could do more than simply ease pain. The epilepsy drug lacosamide appears to block a protein involved in both pain signaling and cartilage destruction, helping damaged joints …
Where this sits on TrendsMap
This story hasn’t been tied to a specific state or province yet — it sits in our United States coverage. We hold 1047 health stories in total, and 36 from Sciencedaily.
This is a summary of reporting by Sciencedaily. Read the full story at the source.
Read full storyPredictions (0)
No predictions yet on this story — be the first to start one.
Comments (0)
GU
posting as a guest
Create a free account to comment under your own name and earn Pulse.